Suppr超能文献

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.

作者信息

Bladh Oscar, Marking Ulrika, Havervall Sebastian, Norin Nina Greilert, Aguilera Katherina, Hober Sophia, Smed-Sörensen Anna, Gordon Max, Blom Kim, Åberg Mikael, Klingström Jonas, Thålin Charlotte

机构信息

Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.

Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.

出版信息

Lancet Microbe. 2023 Jul;4(7):e488. doi: 10.1016/S2666-5247(23)00102-7. Epub 2023 Apr 20.

Abstract
摘要

相似文献

1
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.
Lancet Microbe. 2023 Jul;4(7):e488. doi: 10.1016/S2666-5247(23)00102-7. Epub 2023 Apr 20.
2
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines.
Trends Mol Med. 2023 Apr;29(4):255-267. doi: 10.1016/j.molmed.2023.01.003. Epub 2023 Jan 23.
3
Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine.
Curr Opin Virol. 2023 Oct;62:101347. doi: 10.1016/j.coviro.2023.101347. Epub 2023 Aug 19.
5
Intranasal COVID-19 vaccines: From bench to bed.
EBioMedicine. 2022 Feb;76:103841. doi: 10.1016/j.ebiom.2022.103841. Epub 2022 Jan 24.
6
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 20;98(2):e0154623. doi: 10.1128/jvi.01546-23. Epub 2024 Feb 1.
7
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.
Front Immunol. 2021 Oct 12;12:744887. doi: 10.3389/fimmu.2021.744887. eCollection 2021.
9
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.
EBioMedicine. 2023 Jun;92:104585. doi: 10.1016/j.ebiom.2023.104585. Epub 2023 May 3.
10
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.
Viruses. 2022 Jan 19;14(2):187. doi: 10.3390/v14020187.

引用本文的文献

2
Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination.
Vaccine. 2025 May 22;56:127175. doi: 10.1016/j.vaccine.2025.127175. Epub 2025 Apr 30.
3
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.
JCI Insight. 2025 Mar 10;10(5):e185953. doi: 10.1172/jci.insight.185953.
5
The delivery device of SARS-CoV-2 mucosal vaccine matters.
Nat Immunol. 2024 Oct;25(10):1781-1783. doi: 10.1038/s41590-024-01950-6.
6
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Nat Immunol. 2024 Oct;25(10):1913-1927. doi: 10.1038/s41590-024-01951-5. Epub 2024 Sep 3.
7
Durability of immune responses to SARS-CoV-2 infection and vaccination.
Semin Immunol. 2024 May;73:101884. doi: 10.1016/j.smim.2024.101884. Epub 2024 Jun 10.
8
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
Front Immunol. 2024 Mar 15;15:1346749. doi: 10.3389/fimmu.2024.1346749. eCollection 2024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验